Last reviewed · How we verify
HEC83518 tablets
At a glance
| Generic name | HEC83518 tablets |
|---|---|
| Sponsor | Sunshine Lake Pharma Co., Ltd. |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- The Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of HEC83518 Tablets in Chinses Healthy Subjects (PHASE1)
- the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of HEC83518 Tablets (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- HEC83518 tablets CI brief — competitive landscape report
- HEC83518 tablets updates RSS · CI watch RSS
- Sunshine Lake Pharma Co., Ltd. portfolio CI